Tag: JAMA
Nalu Bio, PIPA Partner on AI Project
SAN FRANCISCO -- Nalu Bio, a biotech company specializing in chemistry-derived cannabinoids, today announced a first-of-its-kind partnership with PIPA, a leader in Nutrition, Health and Wellness...
Study: Cannabis Use Reduces Daily Use of Prescription Opioids in Chronic Pain Patients
Washington, DC --
The use of medical cannabis products is associated with substantial long-term decreases in the daily use of prescription opioids among patients...
Gallup Poll Finds Cannabis Legalization Emerging as Consensus Issue
WASHINGTON, D.C. – According to a new Gallup poll 68 percent of Americans now favor recreational cannabis legalization, representing the highest percentage of support...
FDA Bans Flavored E-Cigarettes and Cartridges
WASHINGTON, D.C. – The U.S. Food and Drug Administration (FDA) released new policy and restrictions on flavored e-cigarettes that amounts to a ban of...
Increasing Study Data Indicates Medical Cannabis Can Reduce Opioid Use, Deaths
Libertarian think tank The Cato Institute last week posted an article citing a study report issued by the Minnesota Department of Health. Study results,...
Cannabis Use Among Expectant Mothers Increasing
The Journal of the American Medical Association, known as JAMA, published on December 26, a research letter on data analysis that indicates cannabis use...
American Medical Association Publishes Op-Ed on Lack of Adequate Cannabis Research
The peer-reviewed Journal of the American Medical Association, or JAMA, this week published an opinion piece addressing inadequate methodology involved in cannabis research, especially...
